Oxford Nanopore Technologies (ONT) Share Price, News & Analysis

Company Overview

Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere.

Key Stats

• Today's Range: 119.90 to 127.20
• 50-Day Range: 115.95 to 135.29
• 52-Week Range: 85 to 169.20
• Volume: 29.42 million shs
• Average Volume: 7.33 million shs
• Market Capitalization: £1.20 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: GBX 233.33
• Consensus Rating: Buy

ONT Stock Analysis - Frequently Asked Questions

How have ONT shares performed this year?

Oxford Nanopore Technologies' stock was trading at GBX 128.80 at the start of the year. Since then, ONT shares have decreased by 1.9% and is now trading at GBX 126.40.
View the best growth stocks for 2025 here.

How were Oxford Nanopore Technologies' earnings last quarter?

Oxford Nanopore Technologies plc (LON:ONT) posted its earnings results on Tuesday, March, 4th. The company reported ($16.00) EPS for the quarter. Oxford Nanopore Technologies had a negative net margin of 94.82% and a negative trailing twelve-month return on equity of 26.02%.
Read the conference call transcript.

How do I buy shares of Oxford Nanopore Technologies?

Shares of ONT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Oxford Nanopore Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Nanopore Technologies investors own include Vodafone Group Public (VOD), easyJet (EZJ), Oxford Nanopore Technologies (ONTTF), BP (BP), Ecora Resources (ECOR), Glencore (GLEN) and HSBC (HSBA).

Company Calendar

• Last Earnings: 3/04/2025
• Today: 6/23/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:ONT
• CIK: N/A
• Web: nanoporetech.com
• Phone: 44 84 5034 7900
• Fax: N/A
• Employees: 1,281
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 233.33
• High Stock Price Target: GBX 260
• Low Stock Price Target: GBX 190
• Potential Upside/Downside: +93.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX (18.58)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£175.21 million
• Net Margins: -94.82%
• Pretax Margin: N/A
• Return on Equity: -26.02%
• Return on Assets: -14.42%

Debt

• Debt-to-Equity Ratio: 8.07
• Current Ratio: 4.45
• Quick Ratio: 6.01

Sales & Book Value

• Annual Sales: £184.78 million
• Price / Sales: 6.19
• Cash Flow: GBX 29.83 per share
• Price / Cash Flow: 4.04
• Book Value: GBX 67.15 per share
• Price / Book: 1.79

Miscellaneous

• Outstanding Shares: 949,046,534
• Free Float: N/A
• Market Cap: £1.14 billion
• Optionable: Not Optionable
• Beta: 0.80